BioClinica expands its app network; Abzena buys a contract drugmaker;

> BioClinica has recruited Medelinked to its network of clinical trial apps, adding the company's electronic patient health record technology to its platform. More

> U.K. service provider Abzena is acquiring the contract drug developer PacificGMP for $7.7 million. News

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.